Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000533706 | SCV000631341 | pathogenic | Dyskeratosis congenita | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 987 of the CTC1 protein (p.Arg987Trp). This variant is present in population databases (rs202138550, gnomAD 0.009%). This missense change has been observed in individuals with Coats plus syndrome (PMID: 22267198, 22899577). ClinVar contains an entry for this variant (Variation ID: 30996). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CTC1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CTC1 function (PMID: 23869908, 24115768). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV001268611 | SCV001447656 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000023987 | SCV002055620 | pathogenic | Cerebroretinal microangiopathy with calcifications and cysts 1 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000023987 | SCV000045278 | pathogenic | Cerebroretinal microangiopathy with calcifications and cysts 1 | 2012-01-22 | no assertion criteria provided | literature only |